Summarized by Masters of Longevity from PR Newswire.
This piece previews a company press release about a new clinical-study-backed outpatient bladder cancer instrument and the start of initial European patient treatments.
Key Takeaways
- The peer-reviewed study reports outpatient treatment and diagnostic sampling for recurrent NMIBC using the Multi4 instrument in awake patients.
- The clinical evaluation included 18 patients at Sahlgrenska University Hospital and demonstrated procedural success and strong safety outcomes.
- Multi4 holds FDA clearance and a CE mark and has initiated European clinic treatments while preparing parallel U.S.
